SCHEMBL7780730

SCHEMBL7780730

N#CCn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(Cl)cc2)c1COCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.54
PTGS1 P23219 5/20 0.54
CHRNA7 P36544 1/20 0.38
CA12 O43570 6/20 0.37
CA1 P00915 6/20 0.37
CA2 P00918 6/20 0.37
CA9 Q16790 6/20 0.37
CA4 P22748 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA5B Q9Y2D0 1/20 0.37
HTR1A P08908 1/20 0.36
HTR2A P28223 1/20 0.36
HTR7 P34969 1/20 0.36
AR P10275 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
MAPK9 P45984 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7778268 0.91 PTGS2 (0.43) PTGS2PTGS1CA12CA1CA2
SCHEMBL7773332 0.91 PTGS2 (0.43) PTGS2PTGS1AR
SCHEMBL7773152 0.89 PTGS2 (0.58) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL7780642 0.88 PTGS2 (0.56) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL8632287 0.87 PTGS2 (0.42) PTGS2PTGS1AR
SCHEMBL7773228 0.87 PTGS2 (0.55) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL7779396 0.85 PTGS2 (0.54) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL7772827 0.83 PTGS2 (0.46) PTGS2PTGS1CA12CA1CA2
SCHEMBL7777782 0.82 PTGS2 (0.50) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL7777935 0.82 PTGS2 (0.46) PTGS2PTGS1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed